Mostrar el registro sencillo del ítem

dc.contributor.authorMarco Rodríguez, Alejandra
dc.contributor.authorPazos Couselo, Marcos 
dc.contributor.authorMoreno-Fernandez, J.
dc.contributor.authorDíez-Fernández, A.
dc.contributor.authorAlonso Sampedro, Manuela
dc.contributor.authorFernández Merino, María del Carmen
dc.contributor.authorGonzález Quintela, Arturo 
dc.contributor.authorGude Sampedro, Francisco 
dc.date.accessioned2025-08-26T10:59:52Z
dc.date.available2025-08-26T10:59:52Z
dc.date.issued2022
dc.identifier.citationMarco A, Pazos-Couselo M, Moreno-Fernandez J, Díez-Fernández A, Alonso-Sampedro M, Fernández-Merino C, et al. Time above range for predicting the development of type 2 diabetes. Frontiers in Public Health. 2022;10.
dc.identifier.issn2296-2565
dc.identifier.otherhttps://portalcientifico.sergas.gal/documentos/63b996de4386723d2da378a9*
dc.identifier.urihttp://hdl.handle.net/20.500.11940/20776
dc.description.abstractAim: To investigate the prognostic value of time range metrics, as measured by continuous glucose monitoring, with respect to the development of type 2 diabetes (T2D). Research design and methods: A total of 499 persons without diabetes from the general population were followed-up for 5 years. Time range metrics were measured at the start and medical records were checked over the period study. Results: Twenty-two subjects (8.3 per 1,000 person-years) developed T2D. After adjusting for age, gender, family history of diabetes, body mass index and glycated hemoglobin concentration, multivariate analysis revealed 'time above range' (TAR, i.e., with a plasma glucose concentration of >140 mg/dL) to be significantly associated with a greater risk (OR = 1.06, CI 1.01-1.11) of developing diabetes (AUC = 0.94, Brier = 0.035). Conclusions: Time above range provides additional information to that offered by glycated hemoglobin to identify patients at a higher risk of developing type 2 diabetes in a population-based study.en
dc.language.isoeng
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleTime above range for predicting the development of type 2 diabetes*
dc.typeArticleen
dc.authorsophosMarco, F. A.
dc.authorsophosPazos-Couselo, M.
dc.authorsophosMoreno-Fernandez, J.
dc.authorsophosDíez-Fernández, A.
dc.authorsophosAlonso-Sampedro, M.
dc.authorsophosFernández-Merino, C.
dc.authorsophosGonzalez-Quintela, A.
dc.authorsophosGude
dc.identifier.doi10.3389/fpubh.2022.1005513
dc.identifier.sophos63b996de4386723d2da378a9
dc.journal.titleFrontiers in Public Health*
dc.relation.publisherversionhttps://www.frontiersin.org/articles/10.3389/fpubh.2022.1005513/pdf;https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1005513/pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordAS Lugoes
dc.subject.keywordHULAes
dc.subject.keywordIDISes
dc.subject.keywordAS Santiago APes
dc.subject.keywordAS Santiagoes
dc.subject.keywordCHUSes
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)es
dc.typesophosArtículo Originales
dc.volume.number10


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional